Form 4/A for KROS Keros Therapeutics, Inc.
Accepted 2025-01-24 00:00:00 ET · period of report 2024-01-04 · accession 0001415889-25-002024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-01-24 | 2024-01-04 | KROS | Regnante Keith | CFO | S - Sale+OE | $45.29 | -40.0K | 0 | -100% | -$1.81M |
| A | 2025-01-24 | 2024-01-04 | KROS | Regnante Keith | CFO | M - OptEx | $16.00 | +40.0K | 40.0K | New | +$640.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | S | D | 40,000 | $45.29 | 0 | D | — | — | (F1) This amendment is being filed to correct the Date of Earliest Transaction and the Transaction Date of each transaction listed in Table I. |
| 2 | Common | Common Stock | 2024-01-04 | M | A | 40,000 | $16.00 | 40,000 | D | — | — | (F1) This amendment is being filed to correct the Date of Earliest Transaction and the Transaction Date of each transaction listed in Table I. |